Please login to the form below

Not currently logged in
Email:
Password:

type 1 diabetes

This page shows the latest type 1 diabetes news and features for those working in and with pharma, biotech and healthcare.

Calliditas bets on PBC drug in Genkyotex buyout

Calliditas bets on PBC drug in Genkyotex buyout

The drug is also being evaluated in a phase 2 clinical trial in type 1 diabetes and kidney disease, and a further phase 2 trial of the drug in IPF is ... A further 10m will be payed following the approval by the FDA or EC in either idiopathic pulmonary

Latest news

  • Key emerging trends in digital health Key emerging trends in digital health

    An exciting development for those living with type 1 diabetes comes from Abbott, a glucose sensing technology company, and Insulet, a diabetes medical device company, who have partnered to develop integrated ... A new start-up app, named Quin, is also

  • FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes

    Last July the FDA also turned down AstraZeneca’s filing for Farxiga in type 1 diabetes, although the drug has been approved in this indication in Europe and Japan. ... The challenges of managing blood sugar levels for those with type 1 diabetes, and

  • Vertex reveals promising data from first CRISPR-treated patients Vertex reveals promising data from first CRISPR-treated patients

    and to continue to accelerate our gene-editing programs for other serious diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1,” he added. ... The American pharma giant also acquired Semma Therapeutics in September, which is

  • FDA advisors say no to empagliflozin in type 1 diabetes FDA advisors say no to empagliflozin in type 1 diabetes

    That means Boehringer and Lilly now have to decide whether approval in type 1 diabetes is worth the cost of running another trial. ... If they do eventually get approval the intention is to sell the drug for type 1 diabetes under a separate brand name.

  • Sanofi reveals positive phase 3 results for long-acting insulin Toujeo Sanofi reveals positive phase 3 results for long-acting insulin Toujeo

    The EDITION JUNIOR study evaluated Toujeo in children and adolescents aged six-to-17-years-old who are living with type 1 diabetes (T1D). ... The company has only just begun to emerge from a difficult period marked by patent losses for big brands,

More from news
Approximately 11 fully matching, plus 138 partially matching documents found.

Latest Intelligence

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    In one example, Provention Bio was forced to temporarily pause a phase 3 study evaluating its investigational therapy for type 1 diabetes. ... Endpoint type – any endpoint that can only be assessed in person or using hospital infrastructure or

  • Growing up as a patient is hard to manage Growing up as a patient is hard to manage

    Chronic diseases and their treatments in general place varying degrees of psychological and behavioural demands on adolescents but there is evidence of rates of adherence differing by disease type, suggesting that ... For adolescents with type 1 diabetes,

  • The fight for affordable insulin The fight for affordable insulin

    After years of steeply rising prices, the issue has hit the national consciousness in the US, and people with type 1 diabetes and their families are taking direct action and coming ... T1International. Elizabeth Pfiester is the founder of T1International,

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    The most heartfelt category of the evening was undoubtedly The People’s Award, which was presented to Beth Baldwin, who lost her son at age 13 to undiagnosed type 1 diabetes ... type 1 diabetes.

  • No incentive for a cure No incentive for a cure

    The paradox of ‘cost-effective but unaffordable’ life-saving medicines. Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to

More from intelligence
Approximately 2 fully matching, plus 22 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy  ... one diabetes (T1D) patients and at-risk individuals and, in

  • JDRF names new CEO JDRF names new CEO

    Derek Rapp to lead diabetes research charity. The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO. ... He now finds himself at the helm of the largest research organisation trying to

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Attigo (part of the Mednet Group) Attigo (part of the Mednet Group)

    For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. ... Including a case study showing the perspective of a young person newly

  • The importance of health literacy in patient recruitment materials

    Figure 1. Type 2 Diabetes (top) and Cancer (bottom) posters that were presented. ... Most appreciated a short and snappy headline, with a positive and upbeat message behind it (Figure 1).

  • Covid-19: what could it mean for the diabetic population?

    body. For those with type 1 diabetes, a condition called Diabetic Ketoacidosis (DKA), is a particular risk if the body starts to run out of insulin. ... vision to prevent type 2 diabetes and even achieve remission for some patients.

  • Mixing up Focus Groups

    Let’s consider a person with Type 1 diabetes, for a moment. ... Wouldn’t that provide a rich, true and insightful understanding of the real world where diabetes is concerned?

  • World Diabetes Day: Interaction and impact of diabetes on mental health

    Including a case study showing the perspective of a young person newly diagnosed with type 1 diabetes. ... and Turner, H.M., 2005. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes.

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...

Infographics